Comparison of two dosing regimens of PEG-interferon beta-1a in volunteers
Phase of Trial: Phase I
Latest Information Update: 16 Jun 2011
At a glance
- Drugs Peginterferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Biogen Idec
- 16 Jun 2011 Results published in the Journal of Clinical Pharmacology, in combination with results from the phase Ia study (see 180253)
- 12 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
- 05 Nov 2010 New trial record.